I
Itzchak Slotki
Researcher at Shaare Zedek Medical Center
Publications - 53
Citations - 1728
Itzchak Slotki is an academic researcher from Shaare Zedek Medical Center. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 18, co-authored 53 publications receiving 1457 citations. Previous affiliations of Itzchak Slotki include Hebrew University of Jerusalem.
Papers
More filters
Journal ArticleDOI
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Iain C. Macdougall,Andreas J. Bircher,Kai-Uwe Eckardt,Gregorio T. Obrador,Carol A. Pollock,Carol A. Pollock,Peter Stenvinkel,Dorine W. Swinkels,Christoph Wanner,Günter Weiss,Glenn M. Chertow,John W. Adamson,Tadao Akizawa,Stefan D. Anker,Michael Auerbach,Peter Bárány,Anatole Besarab,Sunil Bhandari,Ioav Cabantchik,Alan J. Collins,Daniel W. Coyne,Angel L.M. de Francisco,Steven Fishbane,Carlo A. J. M. Gaillard,Tomas Ganz,David Goldsmith,Chaim Hershko,Ewa A. Jankowska,Kirsten L. Johansen,Kamyar Kalantar-Zadeh,Philip A. Kalra,Bertram L. Kasiske,Francesco Locatelli,Jolanta Malyszko,Gert Mayer,Lawrence P. McMahon,Ashraf Mikhail,Elizabeta Nemeth,Amy Barton Pai,Patrick S. Parfrey,Roberto Pecoits-Filho,Simon D. Roger,Guy Rostoker,Jacques Rottembourg,Ajay K. Singh,Itzchak Slotki,Bruce Spinowitz,Der Cherng Tarng,Francesca Tentori,Jorge E. Toblli,Yusuke Tsukamoto,Nosratola D. Vaziri,Wolfgang C. Winkelmayer,David C. Wheeler,Elena Zakharova +54 more
TL;DR: An expert group was convened to assess the benefits and risks of parenteral iron, and to provide strategies for its optimal use while mitigating the risk for acute reactions and other adverse effects.
Journal ArticleDOI
H-Ferritin Subunit Overexpression in Erythroid Cells Reduces the Oxidative Stress Response and Induces Multidrug Resistance Properties
Silvina Epsztejn,Silvina Epsztejn,Hava Glickstein,Hava Glickstein,Virginie Picard,Virginie Picard,Itzchak Slotki,Itzchak Slotki,William Breuer,William Breuer,Carole Beaumont,Carole Beaumont,Z. Ioav Cabantchik,Z. Ioav Cabantchik +13 more
TL;DR: Although enhanced MDR expression per se evoked no significant changes in either LIP levels or ROS production, it might be essential for the survival of H-FT transfectants, possibly by expediting the export of cell-generated metabolites.
Journal ArticleDOI
The cellular labile iron pool and intracellular ferritin in K562 cells.
Abraham M. Konijn,Hava Glickstein,Boris Vaisman,Esther G. Meyron-Holtz,Itzchak Slotki,Z. Ioav Cabantchik +5 more
TL;DR: Findings indicate that, after acute LIP depletion with fast-acting chelators, iron can be mobilized into the LIP from intracellular sources.
Journal ArticleDOI
The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation.
William Breuer,A Ronson,A Ronson,Itzchak Slotki,Itzchak Slotki,A Abramov,A Abramov,Chaim Hershko,Chaim Hershko,Zvi Ioav Cabantchik,Zvi Ioav Cabantchik +10 more
TL;DR: A simple method for NTBI determination is developed, which operates in a 96-well enzyme-linked immunosorbent assay format with sensitivity comparable to that of previous assays, and could provide a useful index of iron status during chelation and supplementation treatments.
Journal ArticleDOI
The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study
Claudia Torino,Luna Gargani,Rosa Sicari,Krzysztof Letachowicz,Robert Ekart,Danilo Fliser,Adrian Covic,Kostas C. Siamopoulos,Aristeidis Stavroulopoulos,Ziad A. Massy,Enrico Fiaccadori,Alberto Caiazza,Thomas Bachelet,Itzchak Slotki,Alberto Martínez-Castelao,Marie-Jeanne Coudert-Krier,Patrick Rossignol,Faikah Gueler,Thierry Hannedouche,Vincenzo Panichi,Andrzej Wiecek,Giuseppe Pontoriero,Pantelis Sarafidis,Marian Klinger,Radovan Hojs,Sarah Seiler-Mussler,Fabio Lizzi,Dimitrie Siriopol,Olga Balafa,Linda Shavit,Rocco Tripepi,Francesca Mallamaci,Giovanni Tripepi,Eugenio Picano,Gérard M. London,Carmine Zoccali +35 more
TL;DR: Lung crackles, either alone or combined with peripheral edema, very poorly reflect interstitial lung edema in patients with ESRD, which reinforces the rationale underlying the Lung Water by Ultra-Sound Guided Treatment to Prevent Death and Cardiovascular Complications in High Risk E SRD Patients with Cardiomyopathy Trial.